Product
RLD2204
1 clinical trial
1 indication
Indication
Peptic UlcerClinical trial
A Multicenter, Randomized, Double-blind, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of HIP0612 in Patients With Gastric UlcerStatus: Not yet recruiting, Estimated PCD: 2023-12-01